Approval · Notice of Compliance 14752 · 2013
SIGNIFOR: Notice of Compliance 14752
Issued September 23, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14752
- Date
- September 23, 2013
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Synthetic pasireotide analogue of somatostatin
Products in this notice
Medicinal ingredients
- PASIREOTIDE 0.3 MG per ML
- PASIREOTIDE 0.6 MG per ML
- PASIREOTIDE 0.9 MG per ML